Dear NNPDF Families and Friends,
Marching right along with October 2014 as GLOBAL NPD Awareness month event, Day 22 day provides us with an opportunity to share research news from the laboratory of Dr. Andrew Munkacsi, who recently completed his Peter G. Pentchev research fellowship.
Trained at Columbia University Medical Center and the University of Minnesota, Dr. Munkacsi is a translational research scientist using high-throughput genomic, lipidomic, and metabolomic approaches to investigate human disease, human nutrition, molecular evolution, and functional biodiversity. His current laboratory at the Victoria University of Wellington opened in July of 2012. Dr. Munkasci’s latest update is of key importance as his work ties to the recently announced NIH Clinical trial for NPC Adults to study the safety and tolerability of vorinostat.
"Defining the molecular basis of HDAC inhibitors to treat murine, feline, and human models of NPC"
Visit the NNPDF Newsline web page to view the final research report: http://www.nnpdf.org/NewsLinePage.html#Oct22